| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.4M | +237.4% |
| Cost of Revenue | $508K | +4.1% |
| Gross Profit | $1.9M | +752.5% |
| R&D Expense | $8.1M | -10.2% |
| SG&A Expense | $10.3M | -9.9% |
| Operating Income | -$16.5M | +21.4% |
| Income Tax | $0 | — |
| Net Income | -$16.0M | +25.4% |
| EPS (Basic) | -$2.62 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $19.2M | +288.6% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $84K | -24.3% |
| Current Assets | $19.6M | +235.6% |
| Total Assets | $25.6M | +111.6% |
| Current Liabilities | $2.6M | -33.6% |
| Total Liabilities | $3.7M | -31.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.9M | +27.0% |
| Capital Expenditures | $655K | +117.6% |
| Investing Cash Flow | -$640K | -107.8% |
| Financing Cash Flow | $28.8M | +447.1% |
| Free Cash Flow | -$14.5M | +24.8% |
| -156.9% |
| EPS (Diluted) | -$2.62 | -156.9% |
| Stockholders' Equity |
| $21.9M |
| +224.7% |